[Hepatitis A from Egypt](http://www.ecdc.europa.eu/en/press/news/Lists/News/ECDC_DispForm.aspx?List=32e43ee8-e230-4424-a783-85742124029a&ID=907&RootFolder=/en/press/news/Lists/News){#interrefs10} {#cesec10}
===================================================================================================================================================================================================

15 confirmed cases of hepatitis A and 89 suspected cases have been reported between November, 2012, and April, 2013, in 14 European countries. All patients had subgenotype IB virus and had travelled to Egypt. Symptoms usually begin 2--6 weeks after exposure to the hepatitis A virus and include dark urine, vomiting, and fatigue. The European Commission, WHO, European Centre for Disease Prevention and Control, and the affected countries are cooperating to monitor the outbreak. Vaccination of contacts of patients should be considered in accordance with national guidance, and hepatitis A vaccination recommendations should be highlighted for people travelling to endemic areas.

[Meningitis in South Sudan](http://allafrica.com/stories/201305010340.html){#interrefs20} {#cesec20}
=========================================================================================

An outbreak of meningitis in the Upper Nile state of South Sudan has been declared by the Ministry of Health on May 2, 2013, after the disease claimed two lives. At least 38 cases have been recorded since the first patient was admitted to hospital on April 15, 2013. The age-group most affected are people aged 18--20 years. Of 11 cerebrospinal fluid samples tested by the ministry so far, eight have been positive for *Neisseria meningitidis* serogroup A, the most prevalent strain in Africa. A mass meningitis vaccination campaign will target over 260 000 people living in the Malakal county and surrounding districts.

[*C diff* in Scotland](http://www.bbc.co.uk/news/uk-scotland-22378210){#interrefs30} {#cesec30}
====================================================================================

A new PCR ribotype of *Clostridium difficile*, designated ribotype 332, has been identified by [Health Protection Scotland (HPS)](http://www.documents.hps.scot.nhs.uk/ewr/pdf2013/1318.pdf){#interrefs40}. The first cases emerged in December, 2012, and January, 2013, from two patients cared for in the same clinical setting in Scotland. The third case was identified from another hospital in April, 2013, within the same National Health Service board. The three patients had reportedly been severely unwell as a result of their underlying disorders and died from the *C difficile* infection. Symptoms of the infection include abdominal cramps and diarrhoea. HPS stated that no immediate changes to surveillance or antibiotic use were necessary.

Novel coronavirus infection {#cesec40}
===========================

WHO continues to receive notification of [confirmed cases](http://www.who.int/csr/don/2013_05_06_ncov/en/index.html){#interrefs50} of infection with the novel coronavirus. On May 3, 2013, two Saudi Arabian patients died and a third was in a critical condition. Patients affected are aged 24--94 years. The [first case](http://www.cbsnews.com/8301-204_162-57583440/new-coronavirus-from-middle-east-infects-french-citizen/){#interrefs60} of the new respiratory virus in France was reported on May 8. Worldwide, 31 cases, including 18 deaths, have been reported since September, 2012. WHO is working with international experts and countries where cases have been reported to assess the situation and review recommendations for surveillance and monitoring.
